Jaguar Gene Therapy Funding: $139M Raised, Series B (2021)
Jaguar Gene Therapy is based in Lake Forest, IL. It has raised $139M in total funding. Latest round: Series B.
Jaguar Gene Therapy funding overview
Jaguar Gene Therapy is based in Lake Forest, IL. Jaguar Gene Therapy has raised $139M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in April 2021. The round record for Jaguar Gene Therapy runs through 2021; nothing later has been disclosed. Investors on record include Eli Lilly and Company, Deerfield Management, ARCH Venture Partners, Goldman Sachs, Nolan Capital. 5 distinct backers are named across the disclosed rounds.
Jaguar Gene Therapy at a glance
Total raised
$139M
Latest round
Series B
Latest round date
April 2021
Headquarters
Lake Forest, IL
Notable investors
Eli Lilly and Company, Deerfield Management, ARCH Venture Partners, Goldman Sachs, Nolan Capital
Frequently asked about Jaguar Gene Therapy funding
How much has Jaguar Gene Therapy raised?
Jaguar Gene Therapy has raised $139M in total disclosed funding across the rounds on record.
Who has invested in Jaguar Gene Therapy?
Eli Lilly and Company, Deerfield Management, ARCH Venture Partners, Goldman Sachs, Nolan Capital are named among the investors backing Jaguar Gene Therapy.
What was the latest Jaguar Gene Therapy funding round?
The most recent disclosed round is a Series B, announced in April 2021.
Where is Jaguar Gene Therapy based?
Jaguar Gene Therapy is based in Lake Forest, IL.
When did Jaguar Gene Therapy last raise?
The last disclosed Jaguar Gene Therapy round closed in April 2021 at Series B.
Jaguar Gene Therapy totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Lake Forest below to benchmark round size and investor mix.
